Published in Cancer Res on February 01, 1985
Understanding the effect of carbonate ion on cisplatin binding to DNA. J Am Chem Soc (2007) 0.99
Core cross-linked block ionomer micelles as pH-responsive carriers for cis-diamminedichloroplatinum(II). J Control Release (2011) 0.98
Reactivity of monofunctional cis-platinum adducts as a function of DNA sequence. Nucleic Acids Res (1988) 0.88
Pharmacokinetics of cisplatin during hyperthermic intraperitoneal treatment of peritoneal carcinomatosis. Eur J Clin Pharmacol (2012) 0.83
The binding of cis-dichlorodiammineplatinum(II) to extracellular and intracellular compounds in relation to drug uptake and cytotoxicity in vitro. Br J Cancer (1992) 0.82
Rearrangement of interstrand cross-links into intrastrand cross-links in cis-diamminedichloroplatinum(II)-modified DNA. Nucleic Acids Res (1997) 0.79
Phosphodiester-mediated reaction of cisplatin with guanine in oligodeoxyribonucleotides. Biochemistry (2008) 0.79
LHRH-targeted nanogels as a delivery system for cisplatin to ovarian cancer. Mol Pharm (2013) 0.78
Monofunctional DNA-platinum(II) adducts block frequently DNA polymerases. Nucleic Acids Res (1992) 0.76
Debio 0507 primarily forms diaminocyclohexane-Pt-d(GpG) and -d(ApG) DNA adducts in HCT116 cells. Cancer Chemother Pharmacol (2011) 0.75
A new fluorometric method for RNA and DNA determination. Anal Biochem (1966) 6.74
Intragenic recombination leads to pilus antigenic variation in Neisseria gonorrhoeae. Nature (1985) 4.60
Role of chromosomal rearrangement in N. gonorrhoeae pilus phase variation. Cell (1985) 3.30
Antigenic variation of gonococcal pilus involves assembly of separated silent gene segments. Proc Natl Acad Sci U S A (1986) 2.53
Use of ethidium bromide for separation and determination of nucleic acids of various conformational forms and measurement of their associated enzymes. Methods Biochem Anal (1971) 2.19
Detection of Candida antigen in sera of patients with candidiasis by an enzyme-linked immunosorbent assay-inhibition technique. J Clin Microbiol (1979) 2.13
Medical psychological observations during the Holocaust: escape into health. Adv Mind Body Med (1999) 2.02
In vitro binding of Candida albicans yeast cells to human fibronectin. Can J Microbiol (1984) 1.98
DNA polyintercalating drugs: DNA binding of diacridine derivatives. Proc Natl Acad Sci U S A (1975) 1.91
DNA Bifunctional intercalators. 2. Fluorescence properties and DNA binding interaction of an ethidium homodimer and an acridine ethidium heterodimer. Biochemistry (1978) 1.86
Inhibitory effects of the tyrosine kinase inhibitor genistein on mammalian DNA topoisomerase II. Cancer Res (1989) 1.82
Ethidium dimer: a new reagent for the fluorimetric determination of nucleic acids. Anal Biochem (1979) 1.81
Stroke volume variation as a predictor of fluid responsiveness in patients undergoing brain surgery. Anesth Analg (2001) 1.75
Recombinant activated factor VII for adjunctive hemorrhage control in trauma. J Trauma (2001) 1.63
Developmental regulation of the cysteine-rich outer-membrane proteins of murine Chlamydia trachomatis. J Gen Microbiol (1988) 1.52
DNA bifunctional intercalators. I. Synthesis and conformational properties of an ethidium homodimer and of an acridine ethidium heterodimer. Biochemistry (1978) 1.51
Biotyping of Candida albicans: results of an international collaborative survey. J Clin Microbiol (1989) 1.50
Evaluation of a new system for the rapid identification of clinically important yeasts. J Clin Microbiol (1976) 1.42
Decay of fluorescence emission anisotropy of the ethidium bromide-DNA complex. Evidence for an internal motion in DNA. Proc Natl Acad Sci U S A (1970) 1.42
In vitro adherence of Candida albicans to human corneocytes. Inhibition by chitin-soluble extract. Acta Derm Venereol (1988) 1.40
The change of the torsion of the DNA helix caused by intercalation. II. Measurement of the relative change of torsion induced by various intercalating drugs. Biochimie (1971) 1.39
Elevated plasma atrial natriuretic peptide levels after occlusion of the thoracic aorta. Chest (1999) 1.37
DNA intercalating compounds as potential antitumor agents. 2. Preparation and properties of 7H-pyridocarbazole dimers. J Med Chem (1980) 1.34
Resonance energy transfer between ethidium bromide molecules bound to nucleic acids. Does intercalation wind or unwind the DNA helix? J Mol Biol (1971) 1.31
Effect of mutation, electric membrane potential, and metabolic inhibitors on the accessibility of nucleic acids to ethidium bromide in Escherichia coli cells. Biochemistry (1984) 1.28
Pathogenesis of vaginal candidiasis: studies with a mutant which has reduced ability to adhere in vitro. J Med Vet Mycol (1986) 1.23
The effect of tidal volume and intravascular volume state on systolic pressure variation in ventilated dogs. Intensive Care Med (1989) 1.20
Effect of 50 S subunit proteins L5, L18 and L25 on the fluorescence of 5 S RNA-bound ethidium bromide. J Mol Biol (1975) 1.20
Adherence of Candida albicans to human vaginal epithelial cells: inhibition by amino sugars. Exp Cell Biol (1982) 1.19
A new antitumoral agent: 9-hydroxyellipticine. Possibility of a rational design of anticancerous drugs in the series of DNA intercalating drugs. Proc Natl Acad Sci U S A (1974) 1.18
Pathology of Shy-Drager syndrome. J Neuropathol Exp Neurol (1979) 1.16
Betulinic acid derivatives: a new class of specific inhibitors of human immunodeficiency virus type 1 entry. J Med Chem (1996) 1.16
[Interaction of ethidium hydrobromate (EH) with polyribonucleotides. Applications to the study of hybridization reactions]. C R Acad Sci Hebd Seances Acad Sci D (1965) 1.15
In vitro and in vivo adherence of Candida albicans to mucosal surfaces. Ann Microbiol (Paris) (1984) 1.14
Mechanisms of action in NIH-3T3 cells of genistein, an inhibitor of EGF receptor tyrosine kinase activity. Biochem Pharmacol (1990) 1.10
Betulinic acid derivatives: a new class of human immunodeficiency virus type 1 specific inhibitors with a new mode of action. J Med Chem (1996) 1.10
Positive end-expiratory pressure-induced hemodynamic changes are reflected in the arterial pressure waveform. Crit Care Med (1996) 1.09
Correlative relationship between adherence of Candida albicans to human vaginal epithelial cells in vitro and candidal vaginitis. Sabouraudia (1984) 1.09
Evaluation of simplified Frykman and AO classifications of fractures of the distal radius. Assessment of interobserver and intraobserver agreement. Int Orthop (1998) 1.09
DNA tris-intercalation: first acridine trimer with DNA affinity in the range of DNA regulatory proteins. Kinetic studies. Biochemistry (1985) 1.07
Initial degradation of deoxyribonucleic acid after injection in mammals. Cancer Res (1965) 1.06
Interaction of Candida albicans with genital mucosal surfaces: involvement of fibronectin in adherence. J Infect Dis (1988) 1.03
Geometry of the antitumor drug ditercalinium bisintercalated into d(CpGpCpG)2 by 1H NMR. Proc Natl Acad Sci U S A (1987) 1.03
Effect of Candida albicans cell wall components on the adhesion of the fungus to human and murine vaginal mucosa. Mycopathologia (1988) 1.01
Measurement of the expected DNA lengthening caused by mono-and bisintercalating drugs using electron microscopy. Biopolymers (1978) 1.01
Synthesis of 11H-pyridocarbazoles and derivatives. Comparison of their DNA binding and antitumor activity with those of 6H- and 7H-pyridocarbazoles. J Med Chem (1986) 0.99
Interaction of cationic porphyrins with DNA: importance of the number and position of the charges and minimum structural requirements for intercalation. Biochemistry (1990) 0.97
Induction of an abortive and futile DNA repair process in E. coli by the antitumor DNA bifunctional intercalator, ditercalinium: role in polA in death induction. Nucleic Acids Res (1988) 0.96
Antitumor activity, pharmacology, and toxicity of ellipticines, ellipticinium, and 9-hydroxy derivatives: preliminary clinical trials of 2-methyl-9-hydroxy ellipticinium (NSC 264-137). Recent Results Cancer Res (1980) 0.94
Attachment of Candida to mammalian tissues--clinical and experimental studies. Zentralbl Bakteriol Mikrobiol Hyg A (1984) 0.93
Adhesion of Candida albicans to mouse intestinal mucosa in vitro: development of the assay and test of inhibitors. J Med Vet Mycol (1986) 0.92
Removal of DNA curving by DNA ligands: gel electrophoresis study. Biochemistry (1991) 0.92
The noncovalent complex between DNA and the bifunctional intercalator ditercalinium is a substrate for the UvrABC endonuclease of Escherichia coli. Proc Natl Acad Sci U S A (1989) 0.92
Dynamic properties of a diluted pyrochlore cooperative paramagnet (Tb(p)Y(1-p))2Ti2O7. Phys Rev Lett (2004) 0.92
Diffuse alveolar hemorrhage in acute promyelocytic leukemia patients treated with ATRA--a manifestation of the basic disease or the treatment. Leuk Lymphoma (2000) 0.92
Corrections for instrumental errors in measurement of fluorescence and polarization of fluorescence. Anal Biochem (1969) 0.91
The use of systolic pressure variation in hemodynamic monitoring during deliberate hypotension in spine surgery. J Clin Anesth (1990) 0.91
Application of transcranial doppler ultrasonography for the diagnosis of brain death. Intensive Care Med (1999) 0.90
Adherence of Candida albicans to buccal and vaginal epithelial cells: ultrastructural observations. Can J Microbiol (1984) 0.90
1H NMR study of an ethidium dimer poly(dA-dT) complex: evidence of a transition between bis and monointercalation. Nucleic Acids Res (1983) 0.90
Isolation of the Candida albicans histidinol dehydrogenase (HIS4) gene and characterization of a histidine auxotroph. J Bacteriol (1990) 0.90
Effects of new antitumor bifunctional intercalators derived from 7H-pyridocarbazole on sensitive and resistant L 1210 cells. Cancer Res (1984) 0.89
Recognition by the DNA repair system of DNA structural alterations induced by reversible drug-DNA interactions. Anticancer Drug Des (1990) 0.88
The use of commercially available lipid emulsions for the preparation of amphotericin B-lipid admixtures. J Antimicrob Chemother (1997) 0.88
Editorial. J Exp Anal Behav (1982) 0.88
A reexamination of the problem of resonance energy transfer between DNA intercalated chromophores using bisintercalating compounds. Nucleic Acids Res (1977) 0.88
Isolation of a petite mutant from a histidine auxotroph of Candida albicans and its characterization. Mycopathologia (1998) 0.88
Respiratory failure and intensive care treatment in bone marrow-transplanted patients. Intensive Care Med (1996) 0.88
Genetic relatedness of Candida albicans to asporogenous and ascosporogenous yeasts as reflected by nucleic acid homologies. Microbios (1974) 0.87
[N-Methyl-9 hydroxy-ellipticine (NSC 264-137) in the treatment of malignant metastases. Preliminary results (author's transl)]. Nouv Presse Med (1981) 0.87
Glucose-6-phosphate dehydrogenase deficiency: possible determinant for a fulminant course of Israeli spotted fever. Isr Med Assoc J (2000) 0.86
Stress, immunity and mycotic diseases. J Med Vet Mycol (1994) 0.86
New strategies in vaccination against fungal infections. J Med Vet Mycol (1994) 0.86
DNA bifunctional intercalators: antileukemic activity of new pyridocarbazole dimers. Biochem Pharmacol (1979) 0.86
Chronic massive knee effusion in familial Mediterranean fever. Semin Arthritis Rheum (1997) 0.85
Zinc-ion binding and cytokine activity regulation pathways predicts outcome in relapsing-remitting multiple sclerosis. Clin Exp Immunol (2007) 0.85
Adhesion of Candida albicans to epithelial cells effect of polyoxin D. Mycopathologia (1991) 0.85
Gonococcal pilus: genetics and structure. Curr Top Microbiol Immunol (1985) 0.84
Experimental vaccination with Candida albicans ribosomes in cyclophosphamide-treated animals. Sabouraudia (1981) 0.84
Susceptibility of Prototheca species to antifungal agents. Antimicrob Agents Chemother (1976) 0.84
Effect of B-Z transition and nucleic acid structure on the conformational dynamics of bound ethidium dimer measured by hydrogen deuterium exchange kinetics. Nucleic Acids Res (1985) 0.84
Hydrogen bonding in deoxyribonucleic acid base recognition. 1. Proton nuclear magnetic resonance studies of dinucleotide-acridine alkylamide complexes. Biochemistry (1981) 0.84
Efficacy of corticosteroids in acute bronchiolitis: short-term and long-term follow-up. Pediatr Pulmonol (1998) 0.83
DNase I susceptibility of bent DNA and its alteration by ditercalinium and distamycin. Biochemistry (1990) 0.83
Epithelial keratitis due to rhodotorula. Ophthalmologica (1973) 0.83
Antifungal activity against Candida albicans of nikkomycin Z in combination with caspofungin, voriconazole or amphotericin B. J Antimicrob Chemother (2008) 0.83
Isolation of Candida tropicalis from an orbital infection as a complication of maxillar osteomyelitis. Infection (1974) 0.83
Relationship between cellular diadenosine 5',5'''-P1,P4-tetraphosphate level, cell density, cell growth stimulation and toxic stresses. Exp Cell Res (1986) 0.83
Systolic pressure variation--a way to recognize dynamic hyperinflation. Br J Anaesth (1996) 0.83
DNA intercalating compounds as potential antitumor agents. 1. Preparation and properties of 7H-pyridocarbazoles. J Med Chem (1980) 0.83
DNA bis-intercalators as new anti-tumour agents: modulation of the anti-tumour activity by the linking chain rigidity in the ditercalinium series. Anticancer Drug Des (1987) 0.82
Interferon and natural killer cell activity in patients with exanthem subitum. Pediatr Infect Dis J (1992) 0.82
[A new antitumor compound: hydroxy-9 ellipticin. Effect on mouse L 1210 leukemia]. C R Acad Sci Hebd Seances Acad Sci D (1973) 0.82
Systemic candidiasis in mice immunized with Candida albicans ribosomes. Mycopathologia (1985) 0.82
[DNA-intercalating compounds. Synthesis of several monomers and 1 dimer of phenanthridinium bearing aminoalkoylated chains]. C R Acad Sci Hebd Seances Acad Sci D (1976) 0.82
Binding of bifunctional ethidium intercalators to transfer RNA. Biochem Biophys Res Commun (1982) 0.82
Cellular actin is affected by interaction with Candida albicans. FEMS Microbiol Lett (2000) 0.82
DNA polyintercalating drugs. Proton magnetic resonance studies of a new acridine dimer. Conformations and interactions with mono- and dinucleotides. Biochemistry (1976) 0.82
[Surgery for thoraco-abdominal aortic aneurysm]. Harefuah (1991) 0.82